Autolus Therapeutics (AUTL) News Today

Autolus Therapeutics (NASDAQ:AUTL) Sees Unusually-High Trading Volume - Here's Why

Millennium Management LLC boosted its stake in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 113.7% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 813,031 shares of the company's stock after acquiring an additional 432,503 shares during the

Autolus Therapeutics (NASDAQ:AUTL) Stock Price Up 5.4% - What's Next?

Perpetual Ltd trimmed its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 33.4% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,599,252 shares of the company's stock after selling 801,160 shares during the quart

Marshall Wace LLP lowered its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 27.1% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 757,535 shares of the company's stock after selling 282,142

Autolus Therapeutics (NASDAQ:AUTL) Shares Up 8.3%

Autolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) was the recipient of a large decrease in short interest in the month of September. As of September 15th, there was short interest totalling 10,730,000 shares, a decrease of 6.1% from the August 31st total of 11,430,000 shares. Based on an average trading volume of 971,000 shares, the days-to-cover ratio is currently 11.1 days.

Renaissance Technologies LLC lifted its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 253.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,145,056 shares of the com

Fred Alger Management LLC lessened its holdings in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 99.1% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 10,262 shares of the company's stock after selli

Armistice Capital LLC increased its position in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 33.8% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 6,250,000 shares of the co

Affinity Asset Advisors LLC increased its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 27.4% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,300,000 shares of the company'

Great Point Partners LLC grew its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 195.0% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,441,667 shares of the co

Autolus Therapeutics (NASDAQ:AUTL) Trading Down 4.8%

HighVista Strategies LLC lifted its holdings in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 98.5% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 518,820 shares of the company's stock after purchasin

Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $4.08

TD Asset Management Inc lessened its stake in Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 39.5% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 207,048 shares of the company's stock

Autolus Therapeutics (NASDAQ:AUTL) Stock Price Down 3.7%

Bank of New York Mellon Corp boosted its stake in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 74.5% during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 2,531,688 shares of the company's

Autolus Therapeutics (NASDAQ:AUTL) Stock Price Up 6%

Autolus Therapeutics (NASDAQ:AUTL) Stock Price Up 2.8%

Autolus Therapeutics (NASDAQ:AUTL) Stock Price Up 3.9%

SG Americas Securities LLC boosted its position in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 853.2% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 189,240 shares of the company's stock after purchasing an a

Autolus Therapeutics (NASDAQ:AUTL) Shares Gap Up to $3.64

Autolus Therapeutics (NASDAQ:AUTL) Stock Price Down 5.2%

Price T Rowe Associates Inc. MD lifted its stake in shares of Autolus Therapeutics plc (NASDAQ:AUTL - Free Report) by 82.9% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 5,488,986 shares of the company's st

Autolus Therapeutics (NASDAQ:AUTL) will be releasing earnings before the market opens on Thursday, August 8, Zacks reports. (Register for Conference Call at http://mmm.wallstreethorizon.com/u.asp?u=437214)

Autolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) was the recipient of a significant increase in short interest in July. As of July 15th, there was short interest totalling 11,900,000 shares, an increase of 74.7% from the June 30th total of 6,810,000 shares. Based on an average daily trading volume, of 1,710,000 shares, the days-to-cover ratio is currently 7.0 days.

Autolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) saw a large growth in short interest during the month of June. As of June 30th, there was short interest totalling 6,810,000 shares, a growth of 5.9% from the June 15th total of 6,430,000 shares. Based on an average daily volume of 1,610,000 shares, the short-interest ratio is presently 4.2 days.

Autolus Therapeutics (NASDAQ:AUTL) Stock Price Up 4.9%

Autolus Therapeutics (NASDAQ:AUTL) Shares Down 5.4%

Autolus Therapeutics (NASDAQ:AUTL) Stock Price Down 5.7%

Autolus Therapeutics plc (NASDAQ:AUTL - Get Free Report) was the target of a significant increase in short interest during the month of June. As of June 15th, there was short interest totalling 6,430,000 shares, an increase of 79.1% from the May 31st total of 3,590,000 shares. Based on an average trading volume of 1,550,000 shares, the short-interest ratio is currently 4.1 days.